换一批
换一批FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters.
作者：
Mengjiao,Li [1]
;
Tatsunori,Nishimura [1]
;
Yasuto,Takeuchi [1]
;
Tsunaki,Hongu [2]
;
Yuming,Wang [1]
;
Daisuke,Shiokawa [1]
;
Kang,Wang [3]
;
Haruka,Hirose [4]
;
Asako,Sasahara [5]
;
Masao,Yano [6]
;
Satoko,Ishikawa [7]
;
Masafumi,Inokuchi [8]
;
Tetsuo,Ota [8]
;
Masahiko,Tanabe [8]
;
Kei-Ichiro,Tada [6]
;
Tetsu,Akiyama [9]
;
Xi,Cheng [10]
;
Chia-Chi,Liu [11]
;
Toshinari,Yamashita [12]
;
Sumio,Sugano [13]
;
Yutaro,Uchida [14]
;
Tomoki,Chiba [15]
;
Hiroshi,Asahara [15]
;
Masahiro,Nakagawa [15]
;
Shinya,Sato [16]
;
Yohei,Miyagi [17]
;
Teppei,Shimamura [17]
;
Luis Augusto E,Nagai [5]
;
Akinori,Kanai [18]
;
Manami,Katoh [19]
;
Seitaro,Nomura [20]
;
Ryuichiro,Nakato [21]
;
Yutaka,Suzuki [20]
;
Arinobu,Tojo [21]
;
Dominic C,Voon [22]
;
Seishi,Ogawa [18]
;
Koji,Okamoto [19]
;
Theodoros,Foukakis [14]
;
Noriko,Gotoh [23]
作者单位：
Division of Cancer Cell Biology, Cancer Research Institute, and.
[1]
Institute for Frontier Science Initiative, Kanazawa University, Kanazawa City, Japan.
[2]
Division of Cancer Differentiation, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.
[3]
Department of Oncology-Pathology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
[4]
Division of Systems Biology, Graduate School of Medicine, Nagoya University, Nagoya City, Japan.
[5]
Department of Breast and Endocrine Surgery, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
[6]
Department of Surgery, Minami-machida Hospital, Machida City, Tokyo, Japan.
[7]
Department of Breast Oncology, Kanazawa University Hospital, Kanazawa City, Japan.
[8]
Department of Breast and Endocrine Surgery, Nihon University, Itabashi-ku, Tokyo, Japan.
[9]
Laboratory of Molecular and Genetic Information, Institute for Quantitative Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
[10]
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
[11]
North Shore Heart Research Group, Kolling Institute, University of Sydney, Sydney, New South Wales, Australia.
[12]
Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama City, Kanagawa, Japan.
[13]
Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
[14]
Department of Systems Biomedicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
[15]
Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
[16]
Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama City, Kanagawa, Japan.
[17]
Laboratory of Computational Genomics, Institute for Quantitative Biosciences.
[18]
Department of Computational Biology and Medical Sciences, Graduate School of Frontier Biosciences.
[19]
Department of Cardiovascular Medicine, Graduate School of Medicine.
[20]
Genome Science Division, Research Center for Advanced Science and Technology.
[21]
Department of Frontier Cardiovascular Science, Graduate School of Medicine, and.
[22]
Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
[23]
Inflammation and Epithelial Plasticity Unit, Cancer Research Institute, Kanazawa University, Kanazawa City, Japan.
[24]
Advanced Comprehensive Research Organization, Teikyo University, Itabashi-ku, Tokyo, Japan.
[25]
主题词
人类(Humans);肿瘤干细胞(Neoplastic Stem Cells);细胞系, 肿瘤(Cell Line, Tumor);膜蛋白质类(Membrane Proteins);肿瘤蛋白质类(Neoplasm Proteins)
DOI
10.1172/JCI166666
PMID
37966117
发布时间
2024-02-14
- 浏览0
The Journal of clinical investigation
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
